-
My Account
My Account
| BUY | SELL | ||
|---|---|---|---|
| QTY | PRICE | PRICE | QTY |
| 122 | 992.00 | 994.90 | 250 |
| 50 | 990.40 | 995.00 | 5 |
| 12 | 990.00 | 996.00 | 15 |
| 10 | 988.00 | 999.40 | 5 |
| 10 | 986.00 | 1000.00 | 55 |
| 2499 | Total | Total | 7830 |
As on 20 Apr, 2021 | 04:00
| BUY | SELL | ||
|---|---|---|---|
| QTY | PRICE | PRICE | QTY |
| 122 | 992.00 | 994.90 | 250 |
| 50 | 990.40 | 995.00 | 5 |
| 12 | 990.00 | 996.00 | 15 |
| 10 | 988.00 | 999.40 | 5 |
| 10 | 986.00 | 1000.00 | 55 |
| 2499 | Total | Total | 7830 |
As on --
(OI , PRICE )
As on --
| Open | 1,011.90 |
| Previous Close | 998.25 |
| UC Limit | 1,098.05 |
| LC Limit | 898.45 |
| Volume | 386,639.00 |
| VWAP | 1,003.98 |
| Mkt Cap (Rs. Cr.) | 19,574 |
| 20D Avg Volume | 413,301 |
| 20D Avg Delivery | 173,474 |
| Beta | 0.260.22 |
| Face Value | 2.00 |
| TTM EPS | 56.36 |
| TTM PE | 17.67 |
| Sector PE | 41.36 |
| Book Value Per Share | 162.39 |
| P/B | 6.13 |
| Dividend Yield | 1.00 |
| P/C | 15.47 |
*Refresh in 20 seconds.
Strong Performer: Stock with good financial performance alongside good to expensive valuation, but lacks price momentum as suggested by technical indicators
indicates Average Financials
| Revenue | 14.1% |
| NetProfit | 27.2% |
| OperatingProfit | 25.7% |
| R1 | R2 | R3 | PP | S1 | S2 | S3 | |
|---|---|---|---|---|---|---|---|
| Classic | - - | - - | - - | - - | - - | - - | - - |
| Fibonacci | - - | - - | - - | - - | - - | - - | - - |
| Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
| R1 | - - | Pivot - - |
S1 | - - |
| R2 | - - | S2 | - - | |
| R3 | - - | S3 | - - |
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
| Days | |
|---|---|
| 5 | - - |
| 10 | - - |
| 20 | - - |
| 50 | - - |
| 100 | - - |
| 200 | - - |
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | - - | - - | - - | - - | - - | - - | - - |
| Fibonacci | - - | - - | - - | - - | - - | - - | - - |
| Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.
| R1 | - - | Pivot - - |
S1 | - - |
| R2 | - - | S2 | - - | |
| R3 | - - | S3 | - - |
Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.
| Days |
|---|
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | - - | - - | - - | - - | - - | - - | - - |
| Fibonacci | - - | - - | - - | - - | - - | - - | - - |
| Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.
| R1 | - - | Pivot - - |
S1 | - - |
| R2 | - - | S2 | - - | |
| R3 | - - | S3 | - - |
Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.
| Days |
|---|
| 1 Week | --% | |
| 1 Month | --% | |
| 3 Months | --% | |
| YTD | --% | |
| 1 Year | --% | |
| 3 Years | --% |
Novel blood cancer drug developed by Alembic Pharma's associate Rhizen gets US approval Feb 09 2021 03:02 PM
Alembic Pharma gets five observations from USFDA for Gujarat facility Feb 08 2021 12:02 PM
Alembic Pharma share price gains on USFDA approval Jan 22 2021 02:01 PM
Alembic Pharma gets USFDA nod for low blood pressure treatment drug Jan 22 2021 11:01 AM
This stock looks Good accumulate every price Can go up very quickly from these levels, watch it ..%u2026tleee...grmmmm.@neha0103 View more
Posted by : rishabh8900
ALEMBIC PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/05/2021 ,inter alia, to consider and approve With reference to the captioned matter, the exchange is hereby informed t...  View more
Posted by : BSE/NSE Announcer
Like a asthmatic patients.. Alembic ka damm phoolne lag gaya h.Managment must be given inhalation 🤣....... YOGESH View more
Posted by : yksaraswat
| Qty 530000 | Price 602 | % Traded 0.27 |
| Qty 170000 | Price 602 | % Traded 0.09 |
| Qty 530000 | Price 602 | % Traded 0.27 |
| Qty 170000 | Price 602 | % Traded 0.09 |
| Qty 1000000 | Price 595 | % Traded 0.51 |
| Qty 1000000 | Price 595 | % Traded 0.51 |
| Qty 800000 | Price 597 | % Traded 0.41 |
| Qty 800000 | Price 597 | % Traded 0.41 |
*Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.
| Qty 1000000 | Price 595 | % Traded 0.51 |
| Qty 1000000 | Price 595 | % Traded 0.51 |
*A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.
| Qty 200000 | Price 940.24 | % Traded 0.10 | Post Tnx Hold. 0% |
| Qty 200000 | Price 935.25 | % Traded 0.10 | Post Tnx Hold. 0% |
| Qty 404025 | Price 931.02 | % Traded 0.21 | Post Tnx Hold. 0.1% |
| Qty 80950 | Price 931.36 | % Traded 0.04 | Post Tnx Hold. 0.1% |
| Qty 284975 | Price 935.36 | % Traded 0.14 | Post Tnx Hold. 28.41% |
| Qty 575 | Price 889.86 | % Traded 0.00 | Post Tnx Hold. 0% |
*Disclosures under SEBI Prohibition of Insider Trading Regulations, 2015
| Qty 0 | Price 0 | % Traded 0.00 | Post Tnx Hold. 69.77% |
| Qty 0 | Price 0 | % Traded 0.00 | Post Tnx Hold. 69.77% |
| Qty 0 | Price 0 | % Traded 0.00 | Post Tnx Hold. 69.77% |
| Qty 0 | Price 0 | % Traded 0.00 | Post Tnx Hold. 0% |
| Qty 0 | Price 0 | % Traded 0.00 | Post Tnx Hold. 72.97% |
| Qty 62275 | Price 0 | % Traded 25.01 | Post Tnx Hold. 0% |
*Disclosures under SEBI SAST (Substantial Acquisition of Shares and Takeovers) Regulations, 2011
| Date | Agenda |
|---|
| Ex-Date | Type | Dividend (%) |
|---|
| Announcement Date | Ex-Bonus | Ratio |
|---|
| Ex-Split | Old FV | New FV |
|---|
| Ex-Right | Ratio | Premium |
|---|
| Date | Agenda |
|---|
| Company Name | Price | % Chg | MCap(Cr) | TTM PE | P/B | ROE | 1 Yr Perform | Net Profit | Net Sales | Debt to Equity |
|---|---|---|---|---|---|---|---|---|---|---|
| Alembic Pharma | 995.80 | -0.25 | 19573.76 | 17.67 | 6.13 | 25.74 | 60.98 | 800 | 4,605 | 0.54 |
| Sun Pharma | 645.15 | 0.70 | 154793.10 | 60.41 | 3.15 | 8.31 | 36.28 | 4,186 | 32,837 | 0.17 |
| Divis Labs | 3779.70 | -0.72 | 100339.16 | 53.64 | 13.73 | 18.83 | 61.35 | 1,376 | 5,394 | 0.00 |
| Dr Reddys Labs | 5156.75 | 3.80 | 85757.39 | 39.42 | 5.50 | 12.98 | 34.12 | 1,969 | 17,517 | 0.11 |
| Cipla | 949.30 | 0.32 | 76557.56 | 34.22 | 4.78 | 9.81 | 62.16 | 1,546 | 17,131 | 0.18 |
Your feedback matters! Tell us what we got right and what we didn’t? Click here>
